Patrick Duane Bhola, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apoptosis | 12 | 2023 | 9511 | 1.280 |
Why?
|
Sports | 1 | 2024 | 698 | 0.580 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2021 | 1151 | 0.550 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1229 | 0.500 |
Why?
|
Mitochondrial Membranes | 4 | 2021 | 184 | 0.490 |
Why?
|
Military Personnel | 1 | 2024 | 1252 | 0.460 |
Why?
|
Permeability | 2 | 2016 | 725 | 0.390 |
Why?
|
Mitochondria | 7 | 2021 | 3670 | 0.390 |
Why?
|
Cells | 1 | 2009 | 162 | 0.300 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2531 | 0.300 |
Why?
|
Aniline Compounds | 3 | 2021 | 1075 | 0.250 |
Why?
|
Cell Line, Tumor | 8 | 2023 | 17062 | 0.240 |
Why?
|
Urodela | 1 | 2024 | 18 | 0.230 |
Why?
|
Mythology | 1 | 2024 | 15 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2018 | 3640 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3605 | 0.200 |
Why?
|
Confusion | 1 | 2024 | 277 | 0.190 |
Why?
|
Sulfonamides | 3 | 2021 | 1981 | 0.190 |
Why?
|
bcl-X Protein | 2 | 2019 | 414 | 0.180 |
Why?
|
Neoplasms | 4 | 2023 | 22345 | 0.170 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2538 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2019 | 5336 | 0.150 |
Why?
|
Leiomyosarcoma | 1 | 2022 | 423 | 0.150 |
Why?
|
Signal Transduction | 4 | 2017 | 23589 | 0.140 |
Why?
|
Granulocyte Precursor Cells | 1 | 2016 | 49 | 0.130 |
Why?
|
Myofibroblasts | 1 | 2017 | 229 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 461 | 0.120 |
Why?
|
Etoposide | 1 | 2016 | 636 | 0.120 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2016 | 169 | 0.120 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 658 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 720 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1409 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 446 | 0.110 |
Why?
|
Antineoplastic Agents | 5 | 2021 | 13639 | 0.110 |
Why?
|
HeLa Cells | 2 | 2009 | 3067 | 0.110 |
Why?
|
Animals | 13 | 2024 | 168731 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2017 | 3717 | 0.110 |
Why?
|
Drug Synergism | 1 | 2017 | 1749 | 0.100 |
Why?
|
Cell Survival | 3 | 2017 | 5747 | 0.100 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 616 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3910 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 994 | 0.090 |
Why?
|
Mice | 9 | 2022 | 81792 | 0.090 |
Why?
|
Protein Kinases | 1 | 2017 | 1611 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1959 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2339 | 0.080 |
Why?
|
Thapsigargin | 1 | 2009 | 102 | 0.080 |
Why?
|
Cytochromes c | 1 | 2009 | 173 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2328 | 0.080 |
Why?
|
NIH 3T3 Cells | 1 | 2009 | 651 | 0.070 |
Why?
|
Caspases | 1 | 2009 | 880 | 0.070 |
Why?
|
Humans | 17 | 2024 | 765734 | 0.070 |
Why?
|
Cytosol | 1 | 2009 | 885 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4352 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8603 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4520 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2822 | 0.060 |
Why?
|
Protons | 1 | 2009 | 1073 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2627 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9299 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 975 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5388 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4900 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2626 | 0.050 |
Why?
|
Naphthoquinones | 1 | 2021 | 61 | 0.050 |
Why?
|
Cell Line | 2 | 2018 | 15542 | 0.040 |
Why?
|
Benzofurans | 1 | 2021 | 140 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2880 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13448 | 0.030 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 70 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4912 | 0.030 |
Why?
|
Calcium | 1 | 2009 | 5765 | 0.030 |
Why?
|
Dermis | 1 | 2017 | 204 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2009 | 3818 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 252 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18289 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2016 | 283 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3539 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2036 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 345 | 0.030 |
Why?
|
Gene Expression | 2 | 2022 | 7584 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1084 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1657 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 540 | 0.030 |
Why?
|
Paclitaxel | 1 | 2019 | 1728 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1964 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9441 | 0.020 |
Why?
|
Time Factors | 2 | 2009 | 40066 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2068 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2229 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1727 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11641 | 0.020 |
Why?
|
Female | 4 | 2021 | 395961 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3948 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 2393 | 0.020 |
Why?
|
Cytokine Receptor gp130 | 1 | 2007 | 66 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8279 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 431 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9548 | 0.020 |
Why?
|
Genomics | 1 | 2019 | 5924 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2007 | 871 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10428 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3585 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3273 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18375 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6272 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22321 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30184 | 0.010 |
Why?
|
Computer Simulation | 1 | 2007 | 6252 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 7424 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14637 | 0.010 |
Why?
|
Male | 2 | 2021 | 363585 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65180 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11888 | 0.010 |
Why?
|